Recombinant DNA (rDNA) technology involves editing DNA to create new synthetic molecules through gene cloning and has historical roots from the early 1970s. Key milestones include the foundational work of Stanley Cohen and Herbert Boyer, and the development of techniques enabling the cloning and expression of genes for human therapy, such as insulin and growth hormones. The technology relies on various tools and methods including restriction endonucleases and vectors for effective gene cloning and manipulation.